Antitumour and Immunomodulatory Effects of Copper Complexes
Author Information
Author(s): Nand K. Singh, Saty B. Singh, Anuraag Shrivastav
Primary Institution: Banaras Hindu University, India and University of Saskatchewan, Canada
Hypothesis
The study investigates the antitumour and immunomodulatory effects of copper(II) complexes of thiobenzhydrazide.
Conclusion
The copper(II) complexes of thiobenzhydrazide exhibit significant antitumour activity and may enhance the immune response in tumour-bearing mice.
Supporting Evidence
- The copper(II) complex [Cu(Htbh)2Cl2] showed the highest antitumour activity.
- Treatment with copper complexes resulted in increased survival rates in tumour-bearing mice.
- Histological studies indicated significant cellular degradation in treated tumour masses.
- Apoptosis was induced in lymphocytes of treated mice, suggesting an immune response.
- Maximum % T/C values were observed for [Cu(Htbh)2Cl2], indicating its potential for further testing.
Takeaway
This study shows that certain copper compounds can help fight cancer and boost the body's immune system.
Methodology
The study involved synthesizing copper(II) complexes, testing their antitumour activity in mice, and evaluating their effects on immune cells.
Limitations
The study does not explore the long-term effects of these complexes or their mechanisms of action in detail.
Participant Demographics
The study used BALB/c mice for testing.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website